GLIMEPIRIDE TABLETS — Class II drug recall D-0046-2015
Terminated recall by Micro Labs Usa, Inc S, reported 2014-11-05, distributed in CT, FL, MD, MS, NY. Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during s
| Recall number | D-0046-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Micro Labs Usa, Inc S, Princeton, NJ, United States |
| Recall initiated | 2014-10-09 |
| Classified | 2014-10-27 |
| Reported by FDA | 2014-11-05 |
| Terminated | 2015-12-29 |
| Distributed | CT, FL, MD, MS, NY |
| Quantity | 11,328 bottles |
| Reason classes | specification failure |
| NDC | 42571-0100, 42571-0100-01, 42571-0100-05, 42571-0101, 42571-0101-01, 42571-0101-05, 42571-0102, 42571-0102-01, 42571-0102-05, 42571-0103, 42571-0103-01, 42571-0103-05, 42571-0104, 42571-0104-01, 42571-0104-05, 42571-0105, 42571-0105-01, 42571-0105-05 |
Product
GLIMEPIRIDE TABLETS, USP 2 mg, a)100 count bottle, (NDC 42571-101-01), b) 500 count Bottle (NDC 42571-101-05), Rx only, Manufactured by: Micro Labs Limited, Goa-403 722, INDIA, Manufactured for: Micro Labs USA, Inc., Princeton, NJ 08540
Reason for recall
Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0046-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.